Comparing the early July spikes for both.
AT1 is pretty much back where it started.
LDX seems to be in the ~10c range after spiking to ~15c. Which is close to 10 times where it was pre-spike.
Given AT1 apparently provides the thing that got approved by the FDA for LDX, the silence from AT1 management about the implications of the approval has been deafening.
GLTYAH. DYOR.
Ann: 2023 Appendix 4G and Corporate Governance Statement, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
